|
|
Article: Sepracor Announces Publication of Additional Data from Lunesta(R) Insomnia-Depression Study in the Journal of Clinical Sleep Medicine.(Clinical report)
- Article from:
- Business Wire
- Article date:
- February 21, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR) today announced that additional data from its Phase IIIB/IV, 545-patient study of LUNESTA([R])brand eszopiclone in patients with insomnia and co-existing major depressive disorder (MDD) have been published in the February 2007 edition of the Journal of Clinical Sleep Medicine. This manuscript contains results from the two-week, single-blind, placebo run-out period of the study that evaluated hypnotic discontinuation effects following an eight-week, placebo-controlled study of LUNESTA and PROZAC([R]) brand fluoxetine co-therapy in patients with insomnia and co-existing MDD.
The double-blind, placebo-controlled ...